drug

CBT-I

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by Jimmi Nielsen
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

1
Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia
NCT06749444—Recruiting

KOLs & investigators

1
Jimmi Nielsen, PhDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Jimmi Nielsen
company
trial
Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia
NA
trial
indication
Treatment-resistant Schizophrenia
indication
Sleep Initiation and Maintenance Disorders
indication
Schizophrenia, Treatment-Resistant
indication
Treatment-refractory Schizophrenia
indication
KOL
Jimmi Nielsen, PhD
KOL score 5
person